Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Immunosuppressed Tumor Microenvironment in MYC -Rearranged High-Grade B-Cell Lymphomas Compared to Diffuse Large B-Cell Lymphomas, Not Otherwise Specified

Blood (2024) 144 (Supplement 1): 4380.

https://doi.org/10.1182/blood-2024-205968

Published: 2024

Journal Articles

Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Blood (2022) 140 (Supplement 1): 369–371.

https://doi.org/10.1182/blood-2022-163244

Published: 2022

Journal Articles

Special Anatomical Subtypes of Diffuse Large B-Cell Lymphoma Have Distinct Tumor Microenvironments

Blood (2022) 140 (Supplement 1): 164–165.

https://doi.org/10.1182/blood-2022-156103

Published: 2022

Journal Articles

Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

Blood (2022) 140 (Supplement 1): 3534–3536.

https://doi.org/10.1182/blood-2022-159036

Published: 2022

Journal Articles

Molecular Diagnostics for TP53 Is Recommended in B-Cell Lymphomas

Lorraine M. De Haan, Ruben A.L. De Groen, Fleur de Groot, Troy Noordenbos, Tom van Wezel, Ronald van Eijk, Dina Ruano, Arjan Diepstra, Lianne Koens, Aniko Sijs-Szabo, Hendrik Veelken, Arjen Cleven, Patty M. Jansen, Joost S.P. Vermaat

Blood (2022) 140 (Supplement 1): 11916–11918.

https://doi.org/10.1182/blood-2022-163197

Published: 2022

Journal Articles

Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study

Mirian Brink, Frederik O. Meeuwes, Marjolein W. M. van der Poel, Marie José Kersten, Mariëlle Wondergem, Pim G. N. J. Mutsaers, Lara H. Böhmer, F. J. Sherida H. Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M. Jansen, Wouter Plattel, Gerwin A. Huls, Joost S. P. Vermaat, Marcel Nijland

Blood (2022) 140 (9): 1009–1019.

https://doi.org/10.1182/blood.2021015114

Published: 2022

Includes: Supplemental data

Journal Articles

First-Line Treatment and Survival of Stage I(E) Peripheral T-Cell Lymphoma in the Netherlands; A Nationwide Population-Based Cohort Study

Frederik O. Meeuwes, Mirian Brink, Marjolein W.M. Van Der Poel, Marie José Kersten, Mariëlle Wondergem, Pim G.N.J. Mutsaers, Lara H. Böhmer, F.J. Sherida H. Woei-a-Jin, Otto J. Visser, Rimke Oostvogels, Patty M. Jansen, Karen J. Neelis, Anne P.G. Crijns, Laurien A. Daniëls, Joost S.P. Vermaat, Gerwin A. Huls, Marcel Nijland

Blood (2021) 138 (Supplement 1): 1381.

https://doi.org/10.1182/blood-2021-148038

Published: 2021

Journal Articles

Outcomes of rare patients with a primary cutaneous CD30 + lymphoproliferative disorder developing extracutaneous disease

Rutger C. Melchers, Rein Willemze, Joost S. P. Vermaat, Patty M. Jansen, Laurien A. Daniëls, Hein Putter, Marcel W. Bekkenk, Ellen R. M. de Haas, Barbara Horvath, Michelle M. van Rossum, Cornelus J. G. Sanders, Joep C. J. M. Veraart, Maarten H. Vermeer, Koen D. Quint

Blood (2020) 135 (10): 769–773.

https://doi.org/10.1182/blood.2019002799

Published: 2020

Includes: Supplemental data

Journal Articles

High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype

Blood (2019) 134 (Supplement_1): 1484.

https://doi.org/10.1182/blood-2019-129832

Published: 2019

Journal Articles

Primary Cutaneous Follicle Center Lymphomas (PCFCL) Express Heavily Mutated B-Cell Receptors with Acquired N-Glycosylation Motifs and Lack Ongoing Somatic Hypermutation

Marvyn T. Koning, BSc, Edwin Quinten, Willem H. Zoutman, Sander A.J. van der Zeeuw, Szymon M. Kielbasa, PhD, Hailang Mei, PhD, Cornelis A.M. van Bergen, PhD, Patty M. Jansen, MD PhD, Rein Willemze, MD PhD, Christian Schmidt, MD, Maarten Vermeer, MD PhD, Cornelis P. Tensen, PhD, Hendrik Veelken, MD PhD

Blood (2018) 132 (Supplement 1): 1573.

https://doi.org/10.1182/blood-2018-99-115134

Published: 2018

Journal Articles

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

Blood (2018) 131 (18): 2086–2089.

https://doi.org/10.1182/blood-2017-12-822817

Published: 2018

Includes: Supplemental data

Journal Articles

No TP63 rearrangements in a selected group of primary cutaneous CD30 + lymphoproliferative disorders with aggressive clinical course

Anne M. R. Schrader, Yan-Yi Chung, Patty M. Jansen, Karoly Szuhai, Armando N. Bastidas Torres, Cornelis P. Tensen, Rein Willemze

Blood (2016) 128 (1): 141–143.

https://doi.org/10.1182/blood-2016-02-694455

Published: 2016

Journal Articles

Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases

Marchina F. Benner, Patty M. Jansen, Maarten H. Vermeer, Rein Willemze

Blood (2012) 119 (7): 1643–1649.

https://doi.org/10.1182/blood-2011-08-376319

Published: 2012

Journal Articles

Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases

Blood (2008) 111 (2): 838–845.

https://doi.org/10.1182/blood-2007-04-087288

Published: 2008

Journal Articles

Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling

Juliette J. Hoefnagel, Remco Dijkman, Katia Basso, Patty M. Jansen, Christian Hallermann, Rein Willemze, Cornelis P. Tensen, Maarten H. Vermeer

Blood (2005) 105 (9): 3671–3678.

https://doi.org/10.1182/blood-2004-04-1594

Published: 2005

Journal Articles

Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas

Jettie J. F. Muris, Saskia A. G. M. Cillessen, Wim Vos, Inge S. van Houdt, J. Alain Kummer, Johan H. J. M. van Krieken, N. Mehdi Jiwa, Patty M. Jansen, Hanneke C. Kluin-Nelemans, Gert J. Ossenkoppele, Chad Gundy, Chris J. L. M. Meijer, Joost J. Oudejans

Blood (2005) 105 (7): 2916–2923.

https://doi.org/10.1182/blood-2004-07-2716

Published: 2005

Journal Articles

EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate

Marcel W. Bekkenk, Maarten H. Vermeer, Chris J. L. M. Meijer, Patty M. Jansen, Jaap M. Middeldorp, Servi J. C. Stevens, Rein Willemze

Blood (2003) 102 (12): 4243.

https://doi.org/10.1182/blood-2003-07-2436

Published: 2003

Journal Articles

Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients

Marcel W. Bekkenk, Maarten H. Vermeer, Patty M. Jansen, Ariënne M. W. van Marion, Marijke R. Canninga-van Dijk, Philip M. Kluin, Marie-Louise Geerts, Chris J. L. M. Meijer, Rein Willemze

Blood (2003) 102 (6): 2213–2219.

https://doi.org/10.1182/blood-2002-07-1960

Published: 2003

Journal Articles

Effect of a Recombinant Dimeric Tumor Necrosis Factor Receptor on Inflammatory Responses to Intravenous Endotoxin in Normal Humans

Tom van der Poll, Susette M. Coyle, Marcel Levi, Patty M. Jansen, Mieke Dentener, Karen Barbosa, Wim A. Buurman, C. Erik Hack, Jan W. ten Cate, Jan M. Agosti, Stephen F. Lowry

Blood (1997) 89 (10): 3727–3734.

https://doi.org/10.1182/blood.V89.10.3727

Published: 1997

NARROW

Immunosuppressed Tumor Microenvironment in MYC -Rearranged High-Grade B-Cell Lymphomas Compared to Diffuse Large B-Cell Lymphomas, Not Otherwise Specified

Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Special Anatomical Subtypes of Diffuse Large B-Cell Lymphoma Have Distinct Tumor Microenvironments

Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

Molecular Diagnostics for TP53 Is Recommended in B-Cell Lymphomas

Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study

First-Line Treatment and Survival of Stage I(E) Peripheral T-Cell Lymphoma in the Netherlands; A Nationwide Population-Based Cohort Study

Outcomes of rare patients with a primary cutaneous CD30 + lymphoproliferative disorder developing extracutaneous disease

High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype

Primary Cutaneous Follicle Center Lymphomas (PCFCL) Express Heavily Mutated B-Cell Receptors with Acquired N-Glycosylation Motifs and Lack Ongoing Somatic Hypermutation

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

No TP63 rearrangements in a selected group of primary cutaneous CD30 + lymphoproliferative disorders with aggressive clinical course

Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases

Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases

Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling

Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas

EBV-positive cutaneous B-cell lymphoproliferative disease after imatinib mesylate

Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients

Effect of a Recombinant Dimeric Tumor Necrosis Factor Receptor on Inflammatory Responses to Intravenous Endotoxin in Normal Humans

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only